Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) Financials
Key financial figures for Rhythm Pharmaceuticals, Inc. Common Stock (Q2 2026).
- Revenue
- $71M
- Net Income
- -$49M
- EPS
- $-0.73
- Total Assets
- $437M
- Operating Cash Flow
- -$9M
Full income statement, balance sheet, and cash flow for Rhythm Pharmaceuticals, Inc. Common Stock on SentiSense.